Yi Elaine Huang

Yi Elaine Huang is a seasoned professional in clinical pharmacology with extensive experience in the biotechnology industry. Currently serving as Associate Director of Clinical Pharmacology in IO at CRISPR Therapeutics since December 2015, Yi Elaine has played a pivotal role in designing critical assays for allogenic CAR-T therapy clinical trials and leads a team for in-house clinical sample testing. Previously, as a Senior Scientist at CRISPR Therapeutics, contributions were made to the validation of genomic assays for early CRISPR-Cas9 clinical trials. Prior experience includes positions at Metamark Genetics, where Yi Elaine significantly contributed to cancer research and biomarker development, as well as roles at Merck Research Laboratory and Joslin Diabetes Center focused on biochemical assays and insulin resistance research, respectively. Yi Elaine holds a Ph.D. in Biochemistry, Cell and Molecular Biology from The Johns Hopkins University School of Medicine and a B.A. in Biology and Chemistry from Bryn Mawr College.